Russian government to allow production of anti-HIV drugs bypassing patent-holders rights

The Russian government is ready to allow the production of anti-HIV drugs bypassing patents of their right-holders, reports The Pharma Letter’s local correspondent.

This will be in the form of the federal law, that will officially come into a force on July 1 of the current year, and will provide the power to the national government to establish the procedure for issuing permits for use of a the drug and its production within Russia without the consent of the patent holder.

In recent years Russia has faced with epidemics of HIV infection, however the government does not have the necessary amount of funds to ensure the purchases needed medicines.